| __timestamp | AbbVie Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 21226345 |
| Thursday, January 1, 2015 | 4285000000 | 87718074 |
| Friday, January 1, 2016 | 4366000000 | 93831530 |
| Sunday, January 1, 2017 | 4982000000 | 79419009 |
| Monday, January 1, 2018 | 10329000000 | 132166913 |
| Tuesday, January 1, 2019 | 6407000000 | 89124838 |
| Wednesday, January 1, 2020 | 6557000000 | 65782137 |
| Friday, January 1, 2021 | 7084000000 | 88845513 |
| Saturday, January 1, 2022 | 6510000000 | 134715000 |
| Sunday, January 1, 2023 | 8453000000 | 180142000 |
| Monday, January 1, 2024 | 12791000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, AbbVie Inc. and Intra-Cellular Therapies, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, AbbVie Inc. consistently allocated substantial resources to R&D, with expenditures peaking in 2018 at over 10 billion dollars. This represents a staggering 213% increase from their 2014 spending. In contrast, Intra-Cellular Therapies, Inc., while significantly smaller in scale, showed a remarkable growth trajectory, increasing their R&D spending by over 750% during the same period.
These figures highlight the diverse strategies within the pharmaceutical industry, where both large-scale investments and agile, focused spending can drive innovation and success.
Comparing Innovation Spending: Novo Nordisk A/S and AbbVie Inc.
AbbVie Inc. or Gilead Sciences, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: AbbVie Inc. vs Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Incyte Corporation
Research and Development Expenses Breakdown: AbbVie Inc. vs Exelixis, Inc.
Comparing Innovation Spending: AbbVie Inc. and Veracyte, Inc.
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Sanofi or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc.
Research and Development Investment: Incyte Corporation vs Intra-Cellular Therapies, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and CymaBay Therapeutics, Inc.